- 1. MEG
- [A drug that belongs to the group of hormones called progestins, used as hormone therapy to block estrogen and to suppress the effects of estrogen and androgens. It is also used to stimulate the appetite in people with cancer. ( NCI )] (UMLS (NCI) C0025175) =Steroid; Pharmacologic Substance; Hormone =Pregnadienes;
[HS800] PROGESTINS =(9beta,10alpha)-17-(Acetyloxy)-6-methylpregna-4,6-diene-3,20-dione | - 13. Megakaryocyte Potentiating Factor
- [An antibody that reacts with ovarian cancers and mesotheliomas was used to isolate a cell surface antigen named mesothelin. Although the function of mesothelin is unknown, it may play a role in cellular adhesion and is present on mesothelium, mesotheliomas, and ovarian cancers. Three transcript variants have been described for this gene and their protein products were initially named megakaryocyte potentiating factor (MPF), mesothelin, and the soluble member(s) of the mesothelin/MPF family. The protein isoform named MPF is a cytokine with megakaryocyte potentiating activity. The soluble member encoded by the third splice variant is detected in ovarian carcinoma; the full length sequence of the third variant has not been described. (LocusLink) ( NCI )] (UMLS (NCI) C0380162) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 2. MeG DNA methyltransferase
- [ ] (UMLS (CSP) C0872349) =Amino Acid, Peptide, or Protein; Enzyme
| - 14. Megakaryocytes Increased in Bone Marrow
- (UMLS (NCI) C0238800) =Finding
|
- 3. mega
- [A prefix indicating a quantity of one million, 10E6. ( NCI )] (UMLS (HL7) C1553028) Mega-;
=Quantitative Concept =UnitOfMeasurePrefixInsens;
| - 15. Megakaryocytic leukemia in remission
- (UMLS (ICD9CM) C0153914) =Neoplastic Process
|
- 4. Megacaryoblast
- [The precursor of a megakaryocyte. ( NCI )] (UMLS (NCI) C0229650) =Cell ;
| - 16. Megakaryocytic leukemia without mention of remission
- (UMLS (ICD9CM) C0153913) =Neoplastic Process
|
- 5. Megace
- (UMLS (NCI) C0700004) =Steroid; Pharmacologic Substance; Hormone
| - 17. Megakaryocytic Neoplasm
- (UMLS (NCI) C1334687) Megakaryocytic Tumor =Neoplastic Process
|
- 6. Megacolon
- [Dilatation of the COLON, often to alarming dimensions. There are various types of megacolon including congenital megacolon in HIRSCHSPRUNG DISEASE, idiopathic megacolon in CONSTIPATION, and TOXIC MEGACOLON. ( MSH )] (UMLS (NCI) C0025160) =Disease or Syndrome =colon disorder;
=aganglionic megacolon;
Megacolon, Toxic;
| - 18. Megakaryocytopoiesis
- [Megakaryopoiesis is the production of megakaryocytes in bone marrow that produce platelets. ( NCI )] (UMLS (NCI) C0522310) =Organ or Tissue Function
|
- 7. MEGACOLON NEC
- [ ] (UMLS (ICD9CM) C0235904) =Disease or Syndrome
| - 19. Megaloblast
- [Red blood cell precursors, corresponding to ERYTHROBLASTS, that are larger than normal, usually resulting from a FOLIC ACID DEFICIENCY or VITAMIN B 12 DEFICIENCY. ( MSH )] (UMLS (NCI) C0025171) =Cell
|
- 8. Megaesophagus
- (UMLS (NCI) C0025164) =Disease or Syndrome
| - 20. MEGALOBLASTIC ANEMIA NEC
- (UMLS (ICD9CM) C0302367) =Disease or Syndrome
|
- 9. MeGAG
- [ ] (UMLS (CSP) C0025716) =Organic Chemical; Pharmacologic Substance ;
| - 21. Megaloblastic Erythroid Hyperplasia
- (UMLS (NCI) C1334688) =Finding
|
- 10. Megahertz
- [The SI derived unit of frequency; equal to one million oscillations per second or to 10E6 hertz. ( NCI )] (UMLS (NCI) C0556962) =Quantitative Concept
| - 22. Megestrol/Omega-3 Fatty acids
- (UMLS (NCI) C1134591) =Therapeutic or Preventive Procedure ;
|
- 11. Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells
- (UMLS (NCI) C1334686) Megakaryoblasts 50% or More of Bone Marrow Nucleated Cells =Laboratory or Test Result
| - 23. MEGLITINIDE
- (UMLS (NCI) C0065880) =Organic Chemical; Pharmacologic Substance ;
|
- 12. megakaryocyte
- [giant cell of bone marrow, a large cell with a greatly lobulated nucleus; mature blood platelets are released from its cytoplasm. ( CSP )] (UMLS (CSP) C0025166) =Cell =hematopoietic stem cell;
| - 24. MEGLUMINE
- [1-Deoxy-1-(methylamino)-D-glucitol. A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium. ( MSH )] (UMLS (NCI) C0025179) =Carbohydrate; Pharmacologic Substance ;
=Hexosamines;
D glucitol;
[AM900] ANTI-INFECTIVES, OTHER;
=1-Deoxy-1-(methylamino)-D-glucitol 3,5-diacetamido-2,4,6-triiodobenzoate (salt);
1-Deoxy-1-(methylamino)-D-glucitol 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate;
MEGLUMINE 0.39 MG/ML |
home
